UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Tonix Pharm Holdings (TNXP)

Tonix Pharm Holdings (TNXP)
17.20 +0.18 (+1.06%) 14:31 ET [NASDAQ]
17.00 x 5 17.18 x 2
Realtime by (Cboe BZX)
17.00 x 5 17.18 x 2
Realtime 17.35 +0.33 (+1.94%) 09:29 ET
News & Headlines for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals Launches TONIX ONE™, a Fully-Integrated Digital Platform Designed to Help Patients Better Understand and Manage Their Migraine Condition

TNXP : 17.19 (+1.00%)
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with...

TNXP : 17.19 (+1.00%)
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Sponsored by The Sustainable Green Team (OTC: SGTM), featuring Kevin Harrington - the ORIGINAL Shark from Shark Tank

RDZN : 0.8888 (+2.23%)
BIVI : 0.8790 (+4.62%)
TNXP : 17.19 (+1.00%)
SGTM : 0.0700 (unch)
Tonix Pharmaceuticals Announces Presentation at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNXP : 17.19 (+1.00%)
Pharma Frenzy: Volatility Ignites Biotech Sector

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

TNXP : 17.19 (+1.00%)
LXEO : 3.64 (+8.01%)
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia

TNXP : 17.19 (+1.00%)
As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread

Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within families and among children, whereas the 2022 Clade II mpox - still spreading -...

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals Stock Dives After Q4 Earnings Miss, But Retail’s Feeling Bullish

Tonix CEO Seth Lederman remains optimistic with the launch of a new drug for the management of pain in Fibromyalgia patients in the pipeline for the fourth quarter (Q4) of 2025.

TNXP : 17.19 (+1.00%)
VXF : 169.29 (+2.33%)
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025

TNXP : 17.19 (+1.00%)
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work...

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th

TNXP : 17.19 (+1.00%)
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

TNXP : 17.19 (+1.00%)
Investors Hit the Jackpot! 8 Micro, Small, and Mid-Cap Stocks That Went Through the Roof

The broader stock market faced renewed selling pressure today, with major indices experiencing sharp declines. The Dow Jones Industrial Average plunged 500 points, extending its recent losing streak as...

CDXC : 7.87 (-0.88%)
MP : 26.11 (+14.07%)
PRTS : 0.9126 (+1.26%)
TNXP : 17.19 (+1.00%)
SITM : 150.21 (+9.05%)
ARBB : 0.7600 (+11.90%)
CMRX : 8.54 (-0.12%)
GV : 1.9700 (+2.07%)
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

TNXP : 17.19 (+1.00%)

Barchart Exclusives

This Under-the-Radar Energy Stock Is Heating Up
Atmos Energy Corporation (ATO) is a regulated natural gas distributor with a strong focus on modernizing its network and reducing regulatory lag. ATO has a 100% technical “buy” signal and is trading above all its daily moving averages. Wall Street analysts and major investing advisory services are bullish, with multiple... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective